Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.68
-0.78 (-7.46%)
Mar 31, 2025, 1:39 PM EDT - Market open
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $226.43 million as of March 31, 2025. Its market cap has increased by 32.19% in one year.
Market Cap
226.43M
Enterprise Value
214.68M
1-Year Change
32.19%
Ranking
Category
Stock Price
$9.68
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $226.43M, an increase of 290.36%. That is a compound annual growth rate of 54.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 244.68M | 134.08% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |